- Home
- MESO vs PENG Comparison
MESO vs PENG Comparison
Compare MESO & PENG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MESO
- PENG
- Stock Information
- Founded
- MESO 2004
- PENG 1988
- Country
- MESO Australia
- PENG United States
- Employees
- MESO N/A
- PENG N/A
- Industry
- MESO Biotechnology: Biological Products (No Diagnostic Substances)
- PENG Semiconductors
- Sector
- MESO Health Care
- PENG Technology
- Exchange
- MESO Nasdaq
- PENG Nasdaq
- Market Cap
- MESO 1.3B
- PENG 1.3B
- IPO Year
- MESO N/A
- PENG 2017
- Fundamental
- Price
- MESO $18.18
- PENG $22.50
- Analyst Decision
- MESO Buy
- PENG Strong Buy
- Analyst Count
- MESO 2
- PENG 8
- Target Price
- MESO $24.00
- PENG $27.50
- AVG Volume (30 Days)
- MESO 319.1K
- PENG 1.8M
- Earning Date
- MESO 08-28-2025
- PENG 10-07-2025
- Dividend Yield
- MESO N/A
- PENG N/A
- EPS Growth
- MESO N/A
- PENG N/A
- EPS
- MESO N/A
- PENG 0.28
- Revenue
- MESO $17,198,000.00
- PENG $1,368,794,000.00
- Revenue This Year
- MESO $288.50
- PENG $11.41
- Revenue Next Year
- MESO $167.17
- PENG $12.79
- P/E Ratio
- MESO N/A
- PENG $79.71
- Revenue Growth
- MESO 191.39
- PENG 16.91
- 52 Week Low
- MESO $7.09
- PENG $14.20
- 52 Week High
- MESO $22.00
- PENG $29.80
- Technical
- Relative Strength Index (RSI)
- MESO 58.45
- PENG 37.36
- Support Level
- MESO $17.10
- PENG $21.10
- Resistance Level
- MESO $20.18
- PENG $29.80
- Average True Range (ATR)
- MESO 0.56
- PENG 1.02
- MACD
- MESO 0.17
- PENG -0.73
- Stochastic Oscillator
- MESO 55.52
- PENG 16.09
About MESO Mesoblast Limited
Mesoblast Ltd is a biotechnology company. It uses its proprietary technology platform to develop and commercialize allogeneic cellular medicines to treat complex diseases resistant to conventional standards of care and where inflammation plays a central role. The company's product candidates include; Ryoncil (remestemcel-L) for the treatment of steroid refractory acute graft versus host disease as well as for the treatment of moderate to severe acute respiratory distress syndrome; Revascor (rexlemestrocel-L) for the treatment of chronic heart failure; and Rexlemestrocel-L for chronic low back pain. The company is managed as one operating segment, being the development of cell technology platform for commercialization.
About PENG Penguin Solutions Inc. Ordinary Shares
Penguin Solutions Inc is an end-to-end technology company engaged in Intelligent Platform Solutions, Integrated Memory, and Optimized LED business. Its product include Servers, software, OCP HPC & AI system, Racks and Edge. Servers include AMD-based Serves, Intel-based Servers, etc. Software products include Scyld ClusterWare, Scyld Cloud Central, etc. OCP HPC & AI Systems includes OCP Servers & Storage and etc.